A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function

Area of Science:

• Immunology
• Vaccinology
• Microbial Pathogenesis

Background:

• * Chlamydia infections cause millions of new cases annually, necessitating improved vaccine development.
• * Understanding cellular immunity, particularly CD4 T cell responses producing IFN-γ, is crucial for Chlamydia vaccine design.
• * Current tools for studying polyfunctional antigen-specific T cells are limited.

Purpose of the Study:

• * To develop a novel tool for studying Chlamydia-specific CD4 T cell responses.
• * To investigate the protective capacity of polyfunctional Th1 T cells against Chlamydia infection.
• * To assess the potential of T cell-based strategies for Chlamydia subunit vaccination.

Main Methods:

• * Creation of a T cell receptor-transgenic (TCR-Tg) mouse model with CD4 T cells recognizing a common Chlamydia antigen.
• * Adoptive transfer of naive TCR-Tg CD4 T cells into infected mice.
• * Analysis of T cell activation, proliferation, migration, phenotype, and effector functions.
• * Evaluation of protection in immune-deficient mouse models.

Main Results:

• * Transferred CD4 T cells activated, proliferated, and migrated to infected tissues.
• * These T cells acquired a polyfunctional Th1 phenotype with enhanced IFN-γ production.
• * Polyfunctional T cells provided protection against lethality, mediated bacterial clearance, and induced memory responses.
• * The TCR-Tg T cells demonstrated superior protective capacity compared to polyclonal cells.

Conclusions:

• * The developed TCR-transgenic mouse model is a powerful tool for analyzing protective T cell responses against Chlamydia.
• * Polyfunctional CD4 T cells play a critical role in controlling Chlamydia infection and establishing immunity.
• * Monoclonal CD4 T cell responses with polyfunctional capacity show promise for guiding subunit vaccination strategies against Chlamydia.